Cleared Traditional

K833155 - RAYDEN MEDICAL MINI PULSE VOLUME RECORD

K833155 is the FDA 510(k) clearance for RAYDEN MEDICAL MINI PULSE VOLUME RECORD by Burditt & Calkins-Siemens-Elema. It is a Class 2 Cardiovascular device (product code DSB) cleared through the Traditional 510(k) pathway after a 133-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
133d
Days
Class 2
Risk

K833155 is an FDA 510(k) clearance for the RAYDEN MEDICAL MINI PULSE VOLUME RECORD. Classified as Plethysmograph, Impedance (product code DSB), Class II - Special Controls.

Submitted by Burditt & Calkins-Siemens-Elema (Walker, US). The FDA issued a Cleared decision on January 26, 1984 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2770 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Burditt & Calkins-Siemens-Elema devices

Submission Details

510(k) Number K833155 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 1983
Decision Date January 26, 1984
Days to Decision 133 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 125d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSB Plethysmograph, Impedance
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.